EW in the 13F filings
Edwards Lifesciences Corp · CUSIP 28176E108
- Quarter end
- 30 Sep 2025
- the date the book describes
- Filed
- 15 Dec 2025
- latest of these filings; the earliest 31 Oct 2025
- Managers listing it
- 22
- at least, of 95 tracked, among listed positions
- Comparable managers
- 95
- filed both Q2 2025 and Q3 2025; 19 listed it in both
- Shares listed
- 64,373,452
- combined, among listed positions
- Reported value
- $5.0bn
- combined, at the quarter end
Among the 95 comparable managers: 9 buyers (opened or added shares) and 15 sellers (trimmed or exited), at least, among listed positions. Their net change in shares is not known from listed positions, because at least one of them lists it in only one of the two quarters.
Managers listing EW in Q3 2025
22 of 22 holders
Largest increases and reductions, by shares
Increases
- Viking Global Investors LPnew position · 3,069,151 shares now+3,069,151
- AQR Capital Management LLCexisting position · 2,081,346 shares now+1,111,139
- Wellington Management Group LLPexisting position · 20,804,416 shares now+977,933
- Acadian Asset Management LLCexisting position · 852,253 shares now+401,257
- Man Group PLCexisting position · 1,967,433 shares now+313,494
Reductions
- Citadel Advisors LLCexisting position · 4,234,570 shares now-8,496,721
- Millennium Management LLCexisting position · 1,779,697 shares now-4,902,303
- Marshall Wace LLPexisting position · 3,566,499 shares now-3,329,080
- Point72 Asset Management LPexisting position · 732,058 shares now-2,307,323
- Woodline Partners LPexisting position · 559,536 shares now-460,443
New positions and exits
New (1)
Exited (2)
- Renaissance Technologies LLCwas $81m
- Freestone Grove Partners LPwas $62m
Ownership over time
Tracked managers listing it, at least.
| Quarter | Holders | Reported value | Buyers | Sellers |
|---|---|---|---|---|
| Q2 2013 | 6 | $2.5bn | n.a. | n.a. |
| Q3 2013 | 14 | $2.3bn | n.a. | n.a. |
| Q4 2013 | 8 | $2.4bn | n.a. | n.a. |
| Q1 2014 | 10 | $2.9bn | n.a. | n.a. |
| Q2 2014 | 7 | $3.0bn | n.a. | n.a. |
| Q3 2014 | 13 | $2.9bn | n.a. | n.a. |
| Q4 2014 | 18 | $3.4bn | n.a. | n.a. |
| Q1 2015 | 18 | $3.1bn | n.a. | n.a. |
| Q2 2015 | 15 | $2.3bn | n.a. | n.a. |
| Q3 2015 | 16 | $2.8bn | n.a. | n.a. |
| Q4 2015 | 19 | $2.7bn | n.a. | n.a. |
| Q1 2016 | 20 | $2.7bn | n.a. | n.a. |
| Q2 2016 | 26 | $3.1bn | n.a. | n.a. |
| Q3 2016 | 21 | $3.8bn | n.a. | n.a. |
| Q4 2016 | 18 | $2.8bn | n.a. | n.a. |
| Q1 2017 | 23 | $2.0bn | n.a. | n.a. |
| Q2 2017 | 21 | $2.8bn | n.a. | n.a. |
| Q3 2017 | 24 | $2.7bn | n.a. | n.a. |
| Q4 2017 | 25 | $2.8bn | n.a. | n.a. |
| Q1 2018 | 23 | $3.7bn | n.a. | n.a. |
| Q2 2018 | 23 | $4.1bn | n.a. | n.a. |
| Q3 2018 | 17 | $5.2bn | n.a. | n.a. |
| Q4 2018 | 21 | $5.0bn | n.a. | n.a. |
| Q1 2019 | 23 | $6.1bn | n.a. | n.a. |
| Q2 2019 | 23 | $5.7bn | n.a. | n.a. |
| Q3 2019 | 24 | $6.7bn | n.a. | n.a. |
| Q4 2019 | 28 | $7.2bn | n.a. | n.a. |
| Q1 2020 | 29 | $5.8bn | n.a. | n.a. |
| Q2 2020 | 30 | $5.9bn | n.a. | n.a. |
| Q3 2020 | 21 | $6.1bn | n.a. | n.a. |
| Q4 2020 | 14 | $6.3bn | n.a. | n.a. |
| Q1 2021 | 22 | $6.0bn | n.a. | n.a. |
| Q2 2021 | 25 | $7.7bn | n.a. | n.a. |
| Q3 2021 | 22 | $8.5bn | n.a. | n.a. |
| Q4 2021 | 20 | $9.2bn | n.a. | n.a. |
| Q1 2022 | 22 | $7.9bn | n.a. | n.a. |
| Q2 2022 | 22 | $6.6bn | n.a. | n.a. |
| Q3 2022 | 29 | $6.2bn | n.a. | n.a. |
| Q4 2022 | 28 | $5.8bn | n.a. | n.a. |
| Q1 2023 | 26 | $5.8bn | n.a. | n.a. |
| Q2 2023 | 25 | $5.9bn | n.a. | n.a. |
| Q3 2023 | 25 | $4.6bn | n.a. | n.a. |
| Q4 2023 | 22 | $5.1bn | 10 | 12 |
| Q1 2024 | 23 | $7.0bn | 14 | 13 |
| Q2 2024 | 20 | $6.8bn | 12 | 11 |
| Q3 2024 | 19 | $3.8bn | 11 | 9 |
| Q4 2024 | 22 | $5.0bn | 12 | 11 |
| Q1 2025 | 23 | $5.0bn | 14 | 11 |
| Q2 2025 | 23 | $5.2bn | 17 | 7 |
| Q3 2025 | 22 | $5.0bn | 9 | 15 |
| Q4 2025 | 23 | $5.9bn | 22 | 14 |
| Q1 2026 | 25 | $6.0bn | 15 | 21 |
| Q2 2026 | 25 | $6.9bn | 18 | 17 |
Compare with…
Holders over time, buyers and sellers, and the managers holding both, side by side for up to four stocks.
EW and LLY →EW and JNJ →EW and VRTX →Choose a stock to compare with EW →
How much of the picture this is
A 13F is a manager’s long US-listed equity book at a quarter end, filed up to 45 days later. It shows no shorts, cash, bonds or performance, and it is never today’s portfolio. Large books are listed to their largest positions, so a manager missing from this table may still hold a small position below that line. These are 95 tracked managers, not the institutional market.
Which funds own EW, latest filings →Back to the 13F Explorer →